Plaza Michael J, Perea Elizabeth, Sanchez-Gonzalez Marcos A
Diagnostic Center for Women, LLC, Miami, FL.
Ponce Health Sciences University School of Medicine, Department of Graduate Medical Education, MD Program, Ponce, Puerto Rico.
J Breast Imaging. 2020 Aug 10;2(4):343-351. doi: 10.1093/jbi/wbaa032.
To compare the performance of abbreviated screening breast MRI (ABMR) versus full protocol MRI (FPMR) in women at higher-than-average risk for breast cancer with a prior normal FPMR.
ABMR was performed on higher-than-average-risk women who had a prior normal FPMR. ABMR protocol consisted of short inversion time inversion recovery imaging, precontrast, and two early postcontrast sequences acquired in under 10 minutes. Retrospective review of ABMR examinations performed from July 2016 to July 2018 was compared with a control group who underwent routine screening with FPMR who had a prior normal FPMR performed from July 2014 to June 2016. Screening outcome metrics were calculated and compared, adjusting for differences in patient demographics.
The study cohort included 481 ABMR examinations, while the control group included 440 FPMR studies. There was no significant difference in the abnormal interpretation rate (AIR) or cancer detection rate (CDR) for the ABMR versus the FPMR group (AIR 6.0% vs 6.8% respectively, odds ratio (OR) 0.91, 95% confidence interval (CI): 0.53-1.5, P = 0.73; CDR 8.3 vs 11 cancers detected per 1000 examinations respectively, OR 0.73, 95% CI: 0.20-2.7, P = 0.64). The PPV2 and PPV3 for the ABMR group was 19% and 21% versus 16% and 16% for the FPMR group, with no statistical difference. Sensitivity was 100% in each group with no interval cancers. There was no difference in specificity between the ABMR and FPMR groups, 93% versus 94%, respectively (P = 0.73).
ABMR may be used to screen higher-than-average-risk women with a prior normal FPMR as outcome metrics are equivalent to FPMR.
比较简化筛查乳腺磁共振成像(ABMR)与全流程磁共振成像(FPMR)在乳腺癌风险高于平均水平且既往FPMR检查正常的女性中的表现。
对既往FPMR检查正常、乳腺癌风险高于平均水平的女性进行ABMR检查。ABMR方案包括短反转时间反转恢复成像、对比剂注射前成像以及在10分钟内采集的两个对比剂注射后早期序列成像。对2016年7月至2018年7月期间进行的ABMR检查进行回顾性分析,并与2014年7月至2016年6月期间接受常规FPMR筛查且既往FPMR检查正常的对照组进行比较。计算并比较筛查结果指标,同时对患者人口统计学差异进行校正。
研究队列包括481例ABMR检查,而对照组包括440例FPMR检查。ABMR组与FPMR组的异常解读率(AIR)或癌症检出率(CDR)无显著差异(AIR分别为6.0%和6.8%,优势比(OR)为0.91,95%置信区间(CI):0.53 - 1.5,P = 0.73;CDR分别为每1000次检查检出8.3例和11例癌症,OR为0.73,95% CI:0.20 - 2.7,P = 0.64)。ABMR组的PPV2和PPV3分别为19%和21%,FPMR组分别为16%和16%,无统计学差异。每组的敏感性均为100%,无间隔期癌症。ABMR组与FPMR组的特异性无差异,分别为93%和94%(P = 0.73)。
由于ABMR的结果指标与FPMR相当,因此ABMR可用于筛查既往FPMR检查正常、乳腺癌风险高于平均水平的女性。